MedPath

Different Bowel Preparations for Colonoscopy In Children

Phase 4
Conditions
Colonoscopy
Interventions
Device: polyethylene glycol 4000 solution with simethicon
Device: PEG-4000 with citrates and simethicone
Device: polyethylene glycol 3350 hyper-osmotic solution with ascorbic acid
Device: sodium picosulphate plus magnesium oxide and citric acid
Registration Number
NCT01711437
Lead Sponsor
Azienda Policlinico Umberto I
Brief Summary

THE AIM OF THIS STUDY IS TO COMPARE THE EFFICACY, TOLERABILITY, AND SAFETY OF DIFFERENT BOWEL PREPARATIONS FOR COLONOSCOPY IN CHILDREN.

THE AIM OF THIS STUDY IS TO COMPARE THE OVERALL COLON CLEANSING

Detailed Description

COLONOSCOPY IS AN ESTABLISHED DIAGNOSTIC AND THERAPEUTIC TOOL IN A VARIETY OF GASTROINTESTINAL TRACT CONDITION AFFECTING CHILDREN AND ADOLESCENTs. FOR EXAMPLE: INFLAMMATORY BOWEL DISEASE, COLONIC POLYPS OR LOWER GASTROINTESTINAL TRACT BLEEDING.

THE IDEAL PREPARATION SHOULD BE OF LOW VOLUME, PALATABLE AND SUCCESSFUL IN COMPLETE COLON CLEANOUT.

PRIMARY AIMS OF THIS WERE TO COMPARE THE EFFICACY AND ACCEPTANCE OF FOUR METHODS OF BOWEL CLEANSING BEFORE COLONOSCOPY IN CHILDREN. SECONDARY AIMS WAS TO COMPARE THE SAFETY PROFILE OF THIS METHODS.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patients undergoing elective colonoscopy in our Institution between 2 and 18 years of age were recruited for this study.
Exclusion Criteria
  1. requirement for urgent colonoscopy,
  2. bowel obstruction,
  3. known or suspected hypersensitivity to the active or other ingredients,
  4. clinically significant electrolyte imbalance,
  5. prior intestinal resection,
  6. known metabolic, renal and cardiac disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PEG-Spolyethylene glycol 4000 solution with simethiconpolyethylene glycol 4000 solution with simethicon
PEG-CS + BisacodylPEG-4000 with citrates and simethiconePEG-CS is a new sulphate-free iso-osmotic formulation of PEG-4000 with citrates and simethicone
PEG-ASCpolyethylene glycol 3350 hyper-osmotic solution with ascorbic acidpolyethylene glycol 3350 hyper-osmotic solution with ascorbic acid
picoprepsodium picosulphate plus magnesium oxide and citric acidsodium picosulphate plus magnesium oxide and citric acid
Primary Outcome Measures
NameTimeMethod
EfficacyDuring the performance of colonoscopy

Preparation efficacy was evaluated by the blinded endoscopist according to the Boston Bowel Preparation scale (BBPS) consisting of four-point scoring system.

The total score ranging from 0 to 9 was divided into four different classes: excellent cleansing (total score 8-9), good cleansing (total score 6-7), poor cleansing (total score 4-5) and inadequate cleansing (total score 0-3).

Secondary Outcome Measures
NameTimeMethod
safety4 days

Adverse events were assessed on the day of colonoscopy by direct questioning and by telephone interview 48-96 hours after colonoscopy.

clinical tolerabiityOn the morning of colonoscopy, immediately before the procedure

Tolerability assessment was based on the recording of occurrence and severity of GI symptoms such as nausea, bloating, abdominal, pain/cramps and anal discomfort

ComplianceOn the morning of colonoscopy, immediately before the procedure

Compliance was scored on a 3-point scale according to the percentage of drunk solution

AcceptabilityOn the morning of colonoscopy, immediately before the procedure

The easiness of taking or swallowing the solution was graded according to the following scale: very severe distress = 4, severe distress = 3, moderate distress = 2, mild distress = 1, no distress = 0.

Trial Locations

Locations (1)

Dipartimento di pediatria e neuropsichiatria Policlinico umberto l "università di roma la sapienza"

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath